Skip to Main Content

Paper Details

A multi-targeting drug design strategy for identifying potent anti-SARS-CoV-2 inhibitors.
Acta Pharmacol Sin
29
2022
Author NameAffiliation
Hualiang Jiangand Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University
Hualiang JiangShanghai Institute of Materia Medica, Chinese Academy of Sciences
Hualiang JiangUniversity of Chinese Academy of Sciences
  • 1 - 3

Datasets

Release 1.2